Letter of Intent: Circular Health Limited to Enhance ECG Smart Ring with AI-Powered Signal Clarity with multi‑year, per‑user SaaS license targeting commercial launch by September 2025. Global growth ...
TORONTO, ON / ACCESS Newswire / January 20, 2026 / NeuralCloud Solutions Inc. ("NeuralCloud"), a subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML) (OTCQB:AIMLF) (FWB:42FB), is ...
A dynamic ECG reporting engine that supports clinical workflows with customizable components and adaptable output structures These patents strengthen AIML's position in the growing field of ...
The electrocardiogram (ECG) remains a cornerstone in cardiovascular diagnostics, yet its clinical utility is often compromised by signal distortions introduced during acquisition. Contemporary ...
Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield™ and CardioYield™. Reinforces competitive advantage as the Company advances ...
Medical Advisory Board will guide clinical studies, regulatory strategy, and global adoption of AIML's AI‑driven ECG signal‑processing solutions MaxYield™ and CardioYield™ across wearables and ...
Pilot Evaluation: Toronto Heart Centre to conduct comparative testing of CardioYield™ for enhanced Holter ECG analysis and reporting efficiency. Clinical Workflow Impact: Study to measure time savings ...
TORONTO, ON / ACCESS Newswire / November 24, 2025 / NeuralCloud Solutions Inc. ("Neural Cloud"), a subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), is ...
Please provide your email address to receive an email when new articles are posted on . Algorithms to improve ECG interpretability received FDA clearance. The solution is designed to reduce noise ...
Peter Kendall, Director, President & Chief Commercialization Officer, AIML"These filings represent more than technical protection-they signal our readiness to commercialize at scale. With a defensible ...
TORONTO, ON / ACCESS Newswire / November 11, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leader in AI-powered physiological signal interpretation, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results